Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study

Background: Few data are available on very long-term follow-up of pediatric multiple sclerosis (MS) patients treated with disease modifying treatments (DMTs). Objectives: To present a long-term follow-up of a cohort of Pediatric-MS patients starting injectable first-line agents. Methods: Data regard...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2019-03, Vol.25 (3), p.399-407
Hauptverfasser:	Baroncini, Damiano, Zaffaroni, Mauro, Moiola, Lucia, Lorefice, Lorena, Fenu, Giuseppe, Iaffaldano, Pietro, Simone, Marta, Fanelli, Fulvia, Patti, Francesco, D’Amico, Emanuele, Capobianco, Marco, Bertolotto, Antonio, Gallo, Paolo, Margoni, Monica, Miante, Silvia, Milani, Nicoletta, Amato, Maria Pia, Righini, Isabella, Bellantonio, Paolo, Scandellari, Cinzia, Costantino, Gianfranco, Scarpini, Elio, Bergamaschi, Roberto, Mallucci, Giulia, Comi, Giancarlo, Ghezzi, Angelo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Age Age Factors Child Disease Progression Encephalopathy Female Follow-Up Studies Glatiramer Acetate - pharmacology Humans Immunologic Factors - administration & dosage Immunologic Factors - pharmacology Injections Interferon Interferon-beta - pharmacology Italy Male Monoclonal antibodies Multiple sclerosis Multiple Sclerosis - drug therapy Multivariate analysis Observational studies Outcome Assessment, Health Care Patients Pediatrics Retrospective Studies Severity of Illness Index Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!